Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer

Download

index.pdf

Date

2017-12-01

Author

TASKOPARAN, Betul
SEZA, Esin Gulce
Demirkol, Secil
TUNCER, Sinem
Stefek, Milan
Gure, Ali Osmay
Banerjee, Sreeparna

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

227
views

0
downloads

Aldo-keto reductases (including AKR1B1 and AKR1B10) constitute a family of oxidoreductases that have been implicated in the pathophysiology of diabetes and cancer, including colorectal cancer (CRC). Available data indicate that, despite their similarities in structure and enzymatic functions, their roles in CRC may be divergent. Here, we aimed to determine the expression and functional implications of AKR1B1 and AKR1B10 in CRC.

Subject Keywords

AKR1B1, AKR1B10, Colorectal cancer, Inflammation, Motility, Prognosis

URI

https://hdl.handle.net/11511/39404

Journal

CELLULAR ONCOLOGY

DOI

https://doi.org/10.1007/s13402-017-0351-7

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

Analyses and modeling of ovarian cancer microarray data Karakelle, Barış S; Purutçuoğlu Gazi, Vilda; Department of Biomedical Engineering (2019) Ovarian cancer is one of the common cancer types among other oncological diseases. The major causes of this cancer can be listed as age, obesity, hormone therapy, material inheritance and contraceptive pills. Due to its generality and importance, many researches have been conducted from distinct labs about this illness and its plausible causes have been intensively investigated either inmicroarray studies, where just part of the related genes are detected, or in thepairwise correlation analyses between the ...
Network-based discovery of molecular targeted agent treatments in hepatocellular carcinoma Fayetörbay, Rumeys; Tunçbağ, Nurcan; Department of Bioinformatics (2020) Hepatocellular carcinoma (HCC) is one of the most-deadly cancers and the most common type of primary liver cancer. Multikinase inhibitor Sorafenib is one of FDA approved targeted agents in HCC treatment. PI3K/AKT/mTOR pathway is altered in about 51% of HCC; hence, understanding how Sorafenib and PI3K/AKT/mTOR pathway inhibitors act at signaling level is crucial for targeted therapies and to reveal the off-target effects. In this work, we use gene expression profiles (GEPs) of HCC cells (Huh7 and Mahlavu) wh...
Investigaton of chemopreventive properties of Urtica Dioica L., in MCF-7 and MDA231 breast cancer cell lines Güler, Elif; İşcan, Mesude; Department of Biology (2011) Cancer is a major health problem in developing world with mostly unsufficient treatment. Cancer prevention through dietary modification appears to be a practical and cost effective possibility. The aim of present study is to investigate the chemical components of “Urtica diocia,L (U. diocia) grown in Turkey” and the possible protective potential of its aqueous extract against breast cancer cell lines. U. diocia was extracted by maceration method which was performed for 6,12, 24, and 36 hours, at 50°C, 37°C,...
Adaptation, reliability and validity study of Type C Behavior Scale Bozo Özen, Özlem; Tathan, Ece (2012-06-01) Objective: The fact that breast cancer is a common type of cancer necessitates the research on the risk factors of it. Studies about type C personality, which is stated to be a risk factor for breast cancer, yielded controversial results regarding type C personality-cancer development relationship. Type C personality has two factors, namely self sacrificing behavior and emotional non-expressiveness. To measure type C personality traits in Turkish breast cancer patients, adaptation of Type C Behavior-TCB Sca...
GST isoenzymes in matched normal and neoplastic breast tissue OĞUZTÜZÜN, SERPİL; Abu-Hijleh, A.; ÇOBAN, TÜLAY; Bulbul, D.; KILIÇ, MURAT; İŞCAN, Mümtaz; İşcan, Mesude (AEPress, s.r.o., 2011-01-01) The potential to metabolize endogenous and exogenous substances may influence breast cancer development and tumor growth. Therefore we investigated GST activity and the protein expression of glutathione S-transferases (GSTs) isoenzymes known to be involved in the metabolism of endogenous and exogenous carcinogens in breast cancer tissue to obtain new information on their possible role in tumor progression.

Citation Formats

B. TASKOPARAN et al., “Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer,” CELLULAR ONCOLOGY, pp. 563–578, 2017, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/39404.